Follow
Mark A. Carty, PhD
Mark A. Carty, PhD
Senior ML Scientist, Tempus Labs
Verified email at tempus.com
Title
Cited by
Cited by
Year
An integrated model for detecting significant chromatin interactions from high-resolution Hi-C data
M Carty, L Zamparo, M Sahin, A González, R Pelossof, O Elemento, ...
Nature communications 8 (1), 15454, 2017
772017
Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia
VR Sanghvi, KJ Mavrakis, J Van der Meulen, M Boice, AL Wolfe, M Carty, ...
Science signaling 7 (352), ra111-ra111, 2014
472014
Reducing bias through process inventory dataset normalization
P White, M Carty
The International Journal of Life Cycle Assessment 15, 994-1013, 2010
192010
Perspectives on ENCODE
F Abascal, R Acosta, NJ Addleman, J Adrian, V Afzal, B Aken, JA Akiyama
Nature 583 (7818), 693-699, 2020
162020
Author Correction: Expanded encyclopaedias of DNA elements in the human and mouse genomes
JE Moore, MJ Purcaro, HE Pratt, CB Epstein, N Shoresh, J Adrian, T Kawli, ...
Nature 605 (7909), E3-E3, 2022
72022
Microrna mediated regulation of hematopoietic stem cell aging
S Yalcin, M Carty, JY Shin, RA Miller, C Leslie, CY Park
Blood 124 (21), 602, 2014
32014
Systems and Methods for Homogenization of Disparate Datasets
T Ahmed, R Pelossof, S Wenric, M Carty
US Patent App. 17/405,025, 2022
22022
Privacy preserving validation for multiomic prediction models
T Ahmed, MA Carty, S Wenric, JR Dry, AA Salahudeen, AA Khan, L Eric, ...
Briefings in Bioinformatics, 1-14, 2022
12022
Transferring diagnostic and prognostic molecular models across technological platforms
T Ahmed, S Wenric, M Carty, R Pelossof
Cancer Res 81, 242, 2021
12021
Towards cancer mega-cohorts: A novel homogenization algorithm applied to diverse breast cancer RNA-Seq datasets.
T Ahmed, M Carty, S Wenric, R Pelossof
Journal of Clinical Oncology 38 (15_suppl), e13507-e13507, 2020
12020
Abstract PO5-24-03: Breast cancer intrinsic subtypes predict outcomes in primary and metastatic samples
T Ahmed, M Carty, K Nadhamuni, R Pelossof
Cancer Research 84 (9_Supplement), PO5-24-03-PO5-24-03, 2024
2024
Identification of poor responders to trastuzumab-deruxtecan with a multi-modal HER2-status predictor
K Nadhamuni, T Ahmed, M Carty, B Terdich, WL Hensing, T Taxter, ...
Cancer Research 84 (6_Supplement), 2502-2502, 2024
2024
185P Real-world data analysis of genomic profiling-matched targeted therapy outcomes in patients with fusion-positive NSCLC
J Patel, R Ben-Shachar, K Nadhamuni, M Carty, R Pelossof, I Klein, ...
Annals of Oncology 34, S255, 2023
2023
Author Correction: Perspectives on ENCODE (Nature,(2020), 583, 7818,(693-698), 10.1038/s41586-020-2449-8)
FBC Abascal, R Acosta, NJ Addleman, J Adrian, V Afzal, B Aken, R Ai, ...
Springer Nature, 2022
2022
Systems and Methods for Homogenization of Disparate Datasets
T Ahmed, R Pelossof, S Wenric, M Carty
US Patent App. 17/548,084, 2022
2022
Systems and Methods for Homogenization of Disparate Datasets
T Ahmed, R Pelossof, S Wenric, M Carty
US Patent App. 17/548,118, 2022
2022
Privacy Preserving RNA-Model Validation Across Laboratories
T Ahmed, MA Carty, S Wenric, JR Dry, AA Salahudeen, AA Khan, ...
bioRxiv, 2021.04. 01.437893, 2021
2021
Perspectives on ENCODE
NJ Addleman, J Adrian, UK Baymuradov, A Bhaskar, N Boley, L Cao, ...
Nature 583 (7818), 693-698, 2020
2020
Practical Analysis of Genome Contact Interaction Experiments
MA Carty, O Elemento
Statistical Genomics: Methods and Protocols, 177-189, 2016
2016
Anti-aging interventions reverse hematopoietic stem cell aging via regulation of micrornas
C Park, S Yalcin, M Carty, J Shin, R Miller, C Leslie
Experimental Hematology 42 (8), S21, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–20